Tandem Diabetes Care Inc (TNDM)
Industry Medical Devices
This stock can be held in an Investment ISA and an Investment Account
Sell
$21.88
Buy
$22.51
$0.27 (+1.24%)
Prices updated at 19 Dec 2025, 22:36 EST
| Prices minimum 15 mins delay
Prices in USD
Tandem Diabetes Care Inc is a provider of medical care devices in the United States. Its products aid in the delivery of insulin and getting accurate readings through its software application.
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
- Key stats
- Price
- Fair value
- Dividends
- News
- Financials
- Valuation
- Profile
Profit margins
Valuation
Profit margins data table
Year | Gross margin (%) |
|---|---|
| 2024 | 52.07 |
| 2023 | 49.18 |
| 2022 | 51.54 |
| 2021 | 53.53 |
| 2020 | 52.23 |
| 2019 | 53.60 |
| 2018 | 48.85 |
| 2017 | 40.98 |
| 2016 | 28.00 |
| 2015 | 36.49 |
Valuation data table
Year | Price / Sales |
|---|---|
| 2025 | 1.46 |
| 2024 | 2.75 |
| 2023 | 2.48 |
| 2022 | 3.65 |
| 2021 | 14.51 |
| 2020 | 13.12 |
| 2019 | 10.49 |
| 2018 | 9.26 |
| 2017 | 0.10 |
| 2016 | 0.77 |
| 2015 | 5.23 |
Price/Forward earnings (YTD)
-25.45
Returns
Debt profile
Returns data table
Year | Return on assets (%) |
|---|---|
| 2024 | -10.00 |
| 2023 | -22.20 |
| 2022 | -9.66 |
| 2021 | 1.92 |
| 2020 | -6.60 |
| 2019 | -9.30 |
| 2018 | -81.30 |
| 2017 | -70.31 |
| 2016 | -70.38 |
| 2015 | -62.65 |
Debt profile data table
| Year | Financial leverage |
|---|---|
| 2024 | 3.68 |
| 2023 | 3.04 |
| 2022 | 2.39 |
| 2021 | 2.09 |
| 2020 | 1.96 |
| 2019 | 1.67 |
| 2018 | 1.57 |
| 2017 | - |
| 2016 | - |
| 2015 | 1.97 |
The figures shown in the Profit Margins table EBITDA column are quoted in the currency of the stock selected.
